Michael S. Ostrach
2017 - Dynavax Technologies
In 2017, Michael S. Ostrach earned a total compensation of $1.8M as Senior Vice President, Chief Financial Officer, Chief Business Officer at Dynavax Technologies, a 61% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $265,625 |
|---|---|
| Salary | $425,000 |
| Stock Awards | $1,126,060 |
| Other | $2,000 |
| Total | $1,818,685 |
Ostrach received $1.1M in stock awards, accounting for 62% of the total pay in 2017.
Ostrach also received $265.6K in non-equity incentive plan, $425K in salary and $2K in other compensation.
Rankings
In 2017, Michael S. Ostrach's compensation ranked 5,966th out of 14,666 executives tracked by ExecPay. In other words, Ostrach earned more than 59.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,966 out of 14,666 | 59th |
Division Manufacturing | 2,183 out of 5,768 | 62nd |
Major group Chemicals And Allied Products | 681 out of 2,074 | 67th |
Industry group Drugs | 527 out of 1,730 | 70th |
Industry Pharmaceutical Preparations | 417 out of 1,329 | 69th |
Source: SEC filing on April 20, 2018.
Ostrach's colleagues
We found four more compensation records of executives who worked with Michael S. Ostrach at Dynavax Technologies in 2017.